1. Home
  2. HBIO vs PRT Comparison

HBIO vs PRT Comparison

Compare HBIO & PRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harvard Bioscience Inc.

HBIO

Harvard Bioscience Inc.

HOLD

Current Price

$8.26

Market Cap

26.5M

Sector

Industrials

ML Signal

HOLD

Logo PermRock Royalty Trust Trust Units

PRT

PermRock Royalty Trust Trust Units

HOLD

Current Price

$1.45

Market Cap

21.5M

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
HBIO
PRT
Founded
1901
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Oil & Gas Production
Sector
Industrials
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
26.5M
21.5M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
HBIO
PRT
Price
$8.26
$1.45
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
13.7K
★ 34.6K
Earning Date
11-05-2026
11-12-2026
Dividend Yield
N/A
★ 13.55%
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $116,176,000.00
N/A
Revenue This Year
$3.76
$654.36
Revenue Next Year
$5.29
N/A
P/E Ratio
★ N/A
$7.78
Revenue Growth
N/A
★ N/A
52 Week Low
$0.40
$1.53
52 Week High
$8.80
$4.01

Technical Indicators

Market Signals
Indicator
HBIO
PRT
Relative Strength Index (RSI) 53.94 17.63
Support Level $5.91 N/A
Resistance Level $8.30 $2.32
Average True Range (ATR) 0.35 0.08
MACD -0.02 -0.03
Stochastic Oscillator 40.56 1.46

Price Performance

Historical Comparison
HBIO
PRT

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.

About PRT PermRock Royalty Trust Trust Units

PermRock Royalty Trust operates as a statutory trust. Its purpose is to own the Net Profits Interest, to distribute to the Trust unitholders cash that it receives in respect of the Net Profits Interest, and to perform certain administrative functions. The Net Profits Interest entitles the trust to receive the net profits from the sale of oil and natural gas production from the underlying properties of its trustor.

Share on Social Networks: